<DOC>
	<DOCNO>NCT02161432</DOCNO>
	<brief_summary>To determine relative bioavailability BI 187004 tablet formulation compare oral solution BI 187004 ass influence food bioavailability tablet formulation .</brief_summary>
	<brief_title>Relative Bioavailability BI 187004 Tablet Formulation Comparison With Oral Solution Influence Food Tablet Formulation Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : 1 . Healthy male subject 2 . Age 18 50 year 3 . Body mass index ( BMI ) 18.5 29.9 kg/m2 Exclusion criterion : 1 . Any finding medical examination ( include BP , pulse rate ( PR ) ECG ) deviate normal judge clinically relevant investigator 2 . Repeated measurement systolic blood pressure outside range 90 140 mmHg , diastolic blood pressure outside range 50 90 mmHg , pulse rate outside range 50 90 bpm 3 . Any laboratory value outside reference range investigator considers clinical relevance 4 . Any evidence concomitant disease judge clinically relevant investigator 5 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 6 . Surgery gastrointestinal tract could interfere kinetics trial medication ( except appendectomy simple hernia repair ) 7 . Diseases central nervous system ( epilepsy ) , neurological disorder psychiatric disorder</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>